• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study Finds Many Recurrent Cystitis Diagnoses Inaccurate While Bladder Retraining Shows Promise

by
November 20, 2026
in Health
Reading Time: 7 mins read
0
Study Finds Many Recurrent Cystitis Diagnoses Inaccurate While Bladder Retraining Shows Promise

Study Finds Many Recurrent Cystitis Diagnoses Inaccurate While Bladder Retraining Shows Promise

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In an observational investigation evaluating women seeking specialized care for recurrent urinary tract infections, researchers discovered that more than half of the participants had been incorrectly diagnosed with isolated recurrent bacterial cystitis. The investigation, published in Infectious Diseases and Therapy under the name URICA study, examined the diagnostic accuracy and clinical outcomes of patients presenting to urology and infectious disease departments across two French university hospitals. Led by Tanguy Maurice, Maxime Vallée, and their colleagues, the medical teams revealed that fifty-five percent of the women initially referred for recurrent cystitis ultimately presented with an alternative pathology or an overlapping condition rather than isolated bacterial infection. Concurrently, for patients who demonstrated confirmed recurrent bacterial infections coupled with acquired functional lower urinary tract dysfunction, the implementation of a structured non-pharmacological regimen known as urinary behavioral therapy resulted in substantial clinical improvement without reliance on continuous antimicrobial regimens.

Recurrent urinary tract infections represent a widespread global health challenge, with over one hundred and fifty million individuals experiencing at least one urinary tract infection episode annually worldwide. Epidemiological data indicate that urinary tract infections predominantly affect women, with nearly one out of every two women experiencing an episode during their lifetime, and twenty-five to thirty percent subsequently developing recurrent infections. According to established SPILF-AFU clinical guidelines, acute recurrent bacterial cystitis in women is defined by the occurrence of at least four episodes of cystitis within a single year. When patients experience more than one episode per month, continuous antibiotic prophylaxis is frequently considered, or management is otherwise individualized through patient-initiated treatment courses. However, repeated antibiotic administration carries significant drawbacks, including long-term alterations of the human microbiota, dysbiosis linked to functional gastrointestinal symptoms and overactive bladder, and the selective pressure driving antimicrobial resistance, which the World Health Organization has designated as a major global threat projected to cause substantial mortality by 2050.

To rigorously investigate diagnostic precision and non-antibiotic intervention outcomes, the investigators conducted a retrospective, descriptive, bicentric study spanning patient consultations between March 2019 and August 2024 at the university hospitals of Poitiers and Nîmes. The study enrolled adult women who consulted a senior urologist or infectious disease specialist for persistent complaints of recurrent urinary tract infections. The protocol systematically excluded male patients and any individuals presenting with febrile urinary tract infections, such as acute pyelonephritis. From an initial identification pool of 255 individuals, 79 patients were excluded, comprising 25 men and 54 individuals evaluated for acute pyelonephritis or other conditions, leaving a primary cohort of 176 women consulting specifically for recurrent acute bacterial cystitis. The study protocol received institutional oversight and approval from the French Data Protection Authority under registration number 30802498, as well as formal approval from the French Urology Research Ethics Committee, which waived the requirement for individual written informed consent.

Classification of the 176 enrolled women was established through expert clinical evaluation by attending senior specialists based on comprehensive clinical histories, voiding diaries, physical examination data, and cystoscopy findings where available. Patients were categorized into two distinct cohorts: those with a confirmed isolated diagnosis of recurrent bacterial cystitis, and those who received an alternative diagnosis or had recurrent cystitis combined with at least one additional disorder. Of the 176 women evaluated, only 77 individuals, representing forty-five percent of the cohort, had an isolated, confirmed diagnosis of recurrent bacterial cystitis. The remaining fifty-five percent received alternative or concurrent diagnoses. The single most common differential condition identified was overactive bladder, diagnosed in an isolated form in 36 patients, accounting for twenty-one percent of the cohort, and diagnosed in conjunction with recurrent cystitis in an additional 14 patients, representing eight percent of the cohort. Other differential diagnoses identified during the specialized evaluations included chronic pelvic pain syndrome, urethritis, and sexually transmitted infections.

Demographic and clinical baseline analyses revealed significant physiological distinctions between the diagnostic groups within the study population. The median age of the overall cohort at the time of initial consultation was 62 years, with an age range spanning from 13 to 84 years, and patients sought specialized medical care after an average disease duration of 5 years. Diabetes mellitus was found to be more prevalent among patients in the confirmed recurrent cystitis group. In contrast, preexisting neurological and gynecological comorbidities, as well as histories of prior pelvic surgeries, were less frequent in the recurrent cystitis group compared with the rest of the study cohort. On physical examination, notable neuromuscular differences emerged: patients diagnosed with recurrent cystitis exhibited significantly fewer perineal contractility disorders than individuals in the non-cystitis cohort, with contractility abnormalities documented in only four percent of recurrent cystitis patients compared to fifteen percent in the remaining population.

Analysis of patient-reported symptoms revealed that no individual clinical symptom was entirely pathognomonic for recurrent bacterial cystitis, though distinct patterns emerged. Urethral burning during micturition was documented in eighty-six percent of patients with confirmed recurrent cystitis, compared with fifty-seven percent of the rest of the population. Conversely, symptoms of urinary urgency were significantly less frequent among patients with recurrent cystitis than in the remaining cohort, occurring in forty percent versus sixty-five percent of individuals, while pyuria was noted in fourteen percent compared to thirty-one percent, respectively. In the overactive bladder subgroup, urgency and pollakiuria were each reported by eighty-six percent of patients, while urethral burning during micturition was still present in fifty-three percent. Among patients with chronic pelvic pain syndrome, predominant clinical manifestations included pelvic heaviness in sixty-nine percent, pollakiuria in sixty-nine percent, and urethral burning during micturition in sixty-one percent, demonstrating that burning sensations alone cannot confirm an infectious diagnosis.

Objective measurements obtained from patient voiding diaries before intervention highlighted functional abnormalities in bladder filling and micturition habits among women with recurrent cystitis. Prior to treatment, patients in the recurrent cystitis group recorded a median maximum voided volume of 500 milliliters, spanning a wide range from 200 to 950 milliliters, an average maximum daytime interval between voiding episodes of 5 hours with an observed range from 0 to 11 hours, and a median 24-hour urine output of 1750 milliliters ranging from 410 to 4500 milliliters. In comparison, women in the non-cystitis cohort recorded lower median maximum voided volumes estimated at 400 milliliters and a shorter median maximum inter-voiding interval of 4 hours. Age-stratified analysis within the recurrent cystitis cohort demonstrated that voiding diary parameters did not differ significantly between patients younger than 45 years and those aged 45 years or older, indicating that delayed voiding and enlarged voided volumes were widespread across adult age groups.

For patients diagnosed with recurrent cystitis stemming from acquired functional lower urinary tract dysfunction, the medical team implemented urinary behavioral therapy, a structured non-drug intervention developed by study author Maxime Vallée. The protocol aims to retrain bladder physiology and re-establish regular bladder emptying by prescribing explicit behavioral parameters: maintaining a maximum voided volume not exceeding 400 milliliters per micturition, ensuring a daytime interval between voids of less than 4 hours, and achieving a total 24-hour voided urine volume between 1.5 liters and 2.0 liters. Patients monitored their adherence using daily voiding diaries. The clinical rationale posits that regular emptying and adequate hydration restore physiological urinary tract defenses, facilitating the mechanical elimination of non-adherent or weakly adherent microorganisms from the bladder urothelium before bacterial proliferation and mucosal invasion can trigger symptomatic acute cystitis.

The therapeutic results of urinary behavioral therapy demonstrated marked clinical improvements in patients monitored over extended follow-up periods. Among the 77 patients diagnosed with isolated recurrent cystitis, 52 were followed for 4 months or longer, and urinary behavioral therapy was formally prescribed to 30 of these individuals. Within this treated subgroup, complete resolution of recurrent cystitis—defined as the total absence of cystitis episodes during follow-up—was achieved in 17 women, representing 56.7 percent. Partial recovery, defined as a reduction of at least 50 percent in recurrent cystitis episodes, occurred in 11 women, representing 36.7 percent. Combined, 28 out of the 30 patients, or 93.3 percent, experienced either complete or partial recovery. Notably, these therapeutic gains occurred even though diary analyses showed that patients had not yet fully achieved all target thresholds, reflecting the time required to modify long-standing voiding habits established since childhood.

Across the broader cohort of 109 patients who completed at least 4 months of clinical follow-up across all diagnostic categories, with a median follow-up duration of 7 months, 92 women, or 84.4 percent, achieved complete or partial recovery following pathology-specific management. In the overall study population of 176 women, complete recovery was documented in 63 patients (36 percent), partial recovery in 56 patients (32 percent), while 25 patients (14 percent) were lost to follow-up, and outcome data were unavailable for 20 patients (11 percent). Economic evaluations highlighted by the authors emphasize that urinary behavioral therapy offers a cost-free alternative to pharmaceutical prophylaxis, avoiding the annual per-patient expenditures associated with preventative drugs such as fosfomycin-trometamol, which averages 292 euros per year, or trimethoprim, which averages approximately 60 euros per year.

The study authors contextualized the behavioral origins of acquired bladder dysfunction, noting that societal and hygiene constraints frequently disrupt physiological voiding patterns in females from early childhood. Effective female voiding requires an unhurried, seated posture that allows complete bladder contraction alongside full relaxation of the urethral striated sphincter and pelvic floor musculature. However, widespread avoidance of public or school restrooms due to inadequate cleanliness, lack of privacy, or social anxiety often leads adolescent girls and women to practice prolonged voluntary urinary retention or crouch in uncomfortable positions. Over time, chronic urine holding can induce vesico-sphincter dyssynergia, blunted bladder sensation, elevated residual capacities, and impaired bacterial clearance. By providing patients with clear, quantifiable voiding diary benchmarks, behavioral therapy provides an accessible framework to counteract learned retention habits.

Despite the positive clinical outcomes, the authors emphasized several methodological limitations inherent to the URICA study design. The research was conducted retrospectively without a randomized control group, and the urinary behavioral therapy protocol was administered primarily by a single urologist at the Poitiers center, introducing potential investigator and center effects. Furthermore, inter-center variations were observed between Poitiers and Nîmes in symptom frequencies, such as urethral burning (91 percent versus 81 percent) and urgency (23.5 percent versus 53 percent). The researchers concluded that while urinary behavioral therapy represents a promising, adverse-effect-free, and antibiotic-sparing strategy for recurrent cystitis associated with functional dysfunction, larger prospective multicenter trials utilizing standardized patient-reported outcome measures are necessary to confirm long-term clinical efficacy.

Subject of Research: Diagnostic accuracy and urinary behavioral therapy outcomes in women with recurrent acute bacterial cystitis

Article Title: URICA Study: Diagnosis and Management of Recurrent Acute Bacterial Cystitis in Women With Urinary Behavioral Therapy

Article References: Maurice, T., Lemetayer, O., Binet, A., Bonduelle, C., Sotto, A., & Vallée, M. (2026). URICA Study: Diagnosis and Management of Recurrent Acute Bacterial Cystitis in Women With Urinary Behavioral Therapy. Infectious Diseases and Therapy, 15(11), 3169-3180. https://doi.org/10.1007/s40121-026-01444-y

Image Credits: AI Generated

DOI: 10.1007/s40121-026-01444-y

Keywords: recurrent cystitis, urinary tract infections, urinary behavioral therapy, overactive bladder, antibiotic sparing, voiding diary, antimicrobial resistance, dysbiosis, micturition, urology, urethral burning, bacterial cystitis, lower urinary tract dysfunction, infectious diseases, pelvic floor, chronic pelvic pain syndrome, URICA study

News Source: Ophelia Keating. (November 20, 2026). Study Finds Many Recurrent Cystitis Diagnoses Inaccurate While Bladder Retraining Shows Promise. Scienmag.

Tags: antibiotic sparingAntimicrobial Resistancebacterial cystitischronic pelvic pain syndromedysbiosisinfectious diseaseslower urinary tract dysfunctionmicturitionoveractive bladderpelvic floorrecurrent cystitisurethral burningURICA studyurinary behavioral therapyurinary tract infectionsurologyvoiding diary
Share12Tweet7Share2ShareShareShare1

Related Posts

Routine Urinalysis Rarely Alters Care During Bladder Cancer Induction Therapy

Routine Urinalysis Rarely Alters Care During Bladder Cancer Induction Therapy

November 20, 2026
Elevated WBC to HDL Ratio Associated With Increased Risk of Stroke

Elevated WBC to HDL Ratio Associated With Increased Risk of Stroke

November 20, 2026

Postpartum Heart Failure Unmasks Rare Congenital Absence of Right Pulmonary Artery

November 20, 2026

Hip Replacement Shows Similar Early Gait Changes Across Osteoarthritis and Femoral Head Osteonecrosis

November 20, 2026

POPULAR NEWS

  • Gene Knockouts and Buffer Systems Boost Bacillus subtilis Spore Display Yields

    Gene Knockouts and Buffer Systems Boost Bacillus subtilis Spore Display Yields

    29 shares
    Share 12 Tweet 7
  • Narrative Review Integrates Imaging, Biomechanics, and Movement in Lumbar Spondylolysis

    29 shares
    Share 12 Tweet 7
  • Bifrontal Brain Stimulation Improves Working Memory in Schizophrenia Without Sex Differences

    29 shares
    Share 12 Tweet 7
  • Robotic and Conventional Knee Replacements Show Comparable One-Year Joint Infection Rates

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Routine Urinalysis Rarely Alters Care During Bladder Cancer Induction Therapy

Elevated WBC to HDL Ratio Associated With Increased Risk of Stroke

Autistic Sensory Sensitivity Varies Strongly by Social Relevance Across Psychophysical Tasks

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.